By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioDelivery Sciences International 

2501 Aerial Center Parkway
Suite 205
Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161



Drug Delivery

Company News
BioDelivery (BDSI) Announces Health Canada Approval Of BELBUCA 6/23/2017 6:59:28 AM
BioDelivery (BDSI) Announces Agreement With CVS/Caremark For BELBUCA And BUNAVAIL Through 2020 6/21/2017 8:22:49 AM
BioDelivery (BDSI) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/16/2017 10:28:46 AM
BioDelivery (BDSI): ~$2 Biopharma Stock On The Cusp Of A Turnaround 5/12/2017 6:30:37 AM
BioDelivery (BDSI) To Host Conference Call And Webcast Reporting First Quarter 2017 Financial Results On Monday, May 15 5/9/2017 11:39:44 AM
BioDelivery (BDSI) Announces The Approval Of BUNAVAIL For Induction Of Buprenorphine Treatment For Opioid Dependence 5/2/2017 6:16:33 AM
BioDelivery (BDSI) Announces The Granting Of Two New Patents To Be Listed In FDA's Orange Book Further Extending And Strengthening Patent Protection On BELBUCA, BUNAVAIL And ONSOLIS 3/31/2017 8:07:05 AM
BioDelivery (BDSI) Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results 3/17/2017 10:51:25 AM
BioDelivery (BDSI) Secures Debt Financing With CRG 2/23/2017 12:09:41 PM
MonoSolRx LLC Release: Company Files Patent Infringement Suit Against BioDelivery (BDSI) 1/16/2017 11:27:09 AM